ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 4 filers reported holding ALKERMES PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,199 | -68.3% | 2,649 | -64.5% | 0.00% | -75.0% |
| Q2 2023 | $233,874 | +162312.5% | 7,472 | +46.6% | 0.01% | +60.0% |
| Q1 2023 | $144 | +166.7% | 5,097 | +148.9% | 0.01% | +150.0% |
| Q4 2022 | $54 | -100.0% | 2,048 | -89.6% | 0.00% | -71.4% |
| Q3 2022 | $440,000 | +16.7% | 19,676 | +55.6% | 0.01% | -12.5% |
| Q2 2022 | $377,000 | +1008.8% | 12,646 | +873.5% | 0.01% | – |
| Q1 2022 | $34,000 | -91.0% | 1,299 | -92.0% | 0.00% | -100.0% |
| Q4 2021 | $378,000 | +94.8% | 16,256 | +157.7% | 0.01% | +40.0% |
| Q3 2021 | $194,000 | +18.3% | 6,309 | -5.8% | 0.01% | +25.0% |
| Q2 2021 | $164,000 | +530.8% | 6,696 | +383.8% | 0.00% | – |
| Q1 2021 | $26,000 | -93.9% | 1,384 | -93.6% | 0.00% | -100.0% |
| Q4 2020 | $429,000 | +304.7% | 21,520 | +236.8% | 0.01% | +1200.0% |
| Q3 2020 | $106,000 | +21.8% | 6,389 | +43.3% | 0.00% | -75.0% |
| Q2 2020 | $87,000 | +2800.0% | 4,457 | +2794.2% | 0.00% | – |
| Q4 2019 | $3,000 | -75.0% | 154 | -73.9% | 0.00% | -100.0% |
| Q3 2019 | $12,000 | +9.1% | 591 | +20.6% | 0.00% | 0.0% |
| Q2 2019 | $11,000 | +266.7% | 490 | +490.4% | 0.00% | – |
| Q1 2019 | $3,000 | -97.6% | 83 | -97.1% | 0.00% | -100.0% |
| Q3 2018 | $123,000 | +127.8% | 2,908 | +123.7% | 0.01% | +200.0% |
| Q2 2018 | $54,000 | -90.5% | 1,300 | -86.8% | 0.00% | -93.9% |
| Q1 2018 | $571,000 | +18933.3% | 9,860 | +15306.2% | 0.05% | – |
| Q3 2017 | $3,000 | -81.2% | 64 | -77.5% | 0.00% | -100.0% |
| Q2 2017 | $16,000 | +220.0% | 284 | +234.1% | 0.00% | +100.0% |
| Q4 2016 | $5,000 | +25.0% | 85 | +1.2% | 0.00% | – |
| Q3 2016 | $4,000 | -84.0% | 84 | -88.5% | 0.00% | -100.0% |
| Q1 2016 | $25,000 | +733.3% | 733 | +1565.9% | 0.00% | – |
| Q3 2015 | $3,000 | -98.4% | 44 | -98.5% | 0.00% | -100.0% |
| Q2 2015 | $186,000 | -8.4% | 2,896 | -13.0% | 0.02% | -36.0% |
| Q1 2015 | $203,000 | +2.0% | 3,327 | -1.9% | 0.02% | +31.6% |
| Q4 2014 | $199,000 | +804.5% | 3,390 | +668.7% | 0.02% | +533.3% |
| Q2 2014 | $22,000 | -8.3% | 441 | -19.7% | 0.00% | 0.0% |
| Q1 2014 | $24,000 | -68.0% | 549 | -70.1% | 0.00% | -76.9% |
| Q4 2013 | $75,000 | +2400.0% | 1,837 | +1737.0% | 0.01% | – |
| Q3 2013 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
| Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
| Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
| Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
| 13D Management LLC | 415,055 | $9,268,000 | 4.85% |
| Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
| GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
| Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
| Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |